2279 — Yonghe Medical Co Income Statement
0.000.00%
- HK$514.77m
- HK$705.07m
- CNY1.80bn
- 57
- 74
- 36
- 60
Annual income statement for Yonghe Medical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,638 | 2,169 | 1,413 | 1,777 | 1,804 |
Cost of Revenue | |||||
Gross Profit | 1,222 | 1,580 | 873 | 997 | 1,084 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,372 | 1,912 | 1,574 | 2,309 | 1,968 |
Operating Profit | 266 | 256 | -162 | -532 | -164 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 231 | 210 | -109 | -585 | -255 |
Provision for Income Taxes | |||||
Net Income After Taxes | 163 | 120 | -85.9 | -547 | -227 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 163 | 120 | -85.9 | -546 | -226 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 163 | 120 | -84 | -538 | -226 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.317 | 0.329 | -0.164 | -0.986 | -0.398 |
Dividends per Share |